CHAPTER 1. INTRODUCTION
1.1.Market Definition
1.2.Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2.Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5.Degree of Competition
3.3.PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing demand for platelet screening programs
4.1.2. Increasing ageing population coupled with growing incidences of target diseases
4.1.3. A wide range of applications such as assessment of surgical bleeding risk and others
4.1.4. Technological advancements in platelet aggregometer
4.1.5. Increasing number of industry-academia collaborations and clinical studies
4.2. Market Restraints & Challenges
4.2.1.High cost and unfavourable healthcare reforms
4.2.2. Lack of skilled professionals
4.2.3. Procedural limitations
4.3. Market Opportunities
4.3.1. R&D development in platelet devices
4.3.2. The emergence of Point-Of-Care & miniaturised platelet aggregometer
CHAPTER 5. GLOBAL PLATELET AGGREGATION DEVICES MARKET– BY
PRODUCT
5.1. Systems
5.2. Reagents
5.3. Consumables & Accessories
CHAPTER 6. GLOBAL PLATELET AGGREGATION DEVICES MARKET – BY
APPLICATION
6.1. Clinical Applications
6.1.1. Cardiovascular
6.1.2. Orthopaedic
6.1.3. Others
6.2. Research Applications
CHAPTER 7. GLOBAL PLATELET AGGREGATION DEVICES MARKET – BY END
USER
7.1. Hospitals
7.2. Academic & Research Institutes
7.3. Diagnostic Laboratories
7.4. Others
CHAPTER 8. GLOBAL PLATELET AGGREGATION DEVICES MARKET - BY
GEOGRAPHY
8.1. Introduction
8.2.North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL PLATELET AGGREGATION DEVICES MARKET -
COMPANY PROFILES
9.1. Siemens AG
9.2. Helena Laboratories Corporation
9.3. Haemonetics Corporation
9.4. Accriva Diagnostics
9.5. F- Hoffmann-La Roche Ltd.
9.6. TEM Group
9.7. Sentinel Ch. S.p.A.
9.8. Aggredyne, Inc.
9.9. Sysmex Corporation
9.10. Bio/Data Corporation
9.11. Chrono-log Corporation
9.12. Drucker Diagnostics
9.13. LaborBioMedical Technologies
9.14. Matis Medical
CHAPTER 10. GLOBALPLATELET AGGREGATION DEVICES MARKET -
COMPETITIVE LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
